Janney Capital Management LLC decreased its holdings in MetLife, Inc. (NYSE:MET – Free Report) by 0.7% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 40,090 shares of the financial services provider’s stock after selling 300 shares during the period. Janney Capital Management LLC’s holdings in MetLife were worth $3,283,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Daymark Wealth Partners LLC increased its position in shares of MetLife by 3.0% during the fourth quarter. Daymark Wealth Partners LLC now owns 5,091 shares of the financial services provider’s stock valued at $417,000 after buying an additional 149 shares during the period. Global Trust Asset Management LLC bought a new position in MetLife during the 4th quarter valued at about $50,000. Nisa Investment Advisors LLC grew its position in MetLife by 0.3% in the 4th quarter. Nisa Investment Advisors LLC now owns 205,916 shares of the financial services provider’s stock worth $16,860,000 after purchasing an additional 631 shares during the period. Simon Quick Advisors LLC boosted its stake in shares of MetLife by 13.0% during the 4th quarter. Simon Quick Advisors LLC now owns 4,194 shares of the financial services provider’s stock worth $343,000 after acquiring an additional 483 shares during the last quarter. Finally, Atomi Financial Group Inc. increased its position in MetLife by 9.0% in the fourth quarter. Atomi Financial Group Inc. now owns 6,638 shares of the financial services provider’s stock worth $544,000 after buying an additional 548 shares in the last quarter. 94.99% of the stock is owned by institutional investors.
MetLife Stock Performance
MetLife stock opened at $86.09 on Wednesday. The company has a market cap of $59.61 billion, a PE ratio of 17.38, a P/E/G ratio of 0.66 and a beta of 1.07. The company has a fifty day moving average price of $83.60 and a two-hundred day moving average price of $79.78. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.16 and a quick ratio of 0.16. MetLife, Inc. has a 12 month low of $64.61 and a 12 month high of $89.05.
MetLife Announces Dividend
Analyst Upgrades and Downgrades
Several analysts recently issued reports on the company. Barclays lifted their target price on MetLife from $90.00 to $96.00 and gave the company an “overweight” rating in a research note on Monday, January 6th. TD Cowen increased their target price on MetLife from $97.00 to $99.00 and gave the stock a “buy” rating in a research note on Wednesday, November 27th. StockNews.com lowered shares of MetLife from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. Wells Fargo & Company cut their price objective on shares of MetLife from $93.00 to $92.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 14th. Finally, Piper Sandler raised their price target on shares of MetLife from $85.00 to $92.00 and gave the stock an “overweight” rating in a report on Wednesday, October 2nd. One equities research analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, MetLife presently has an average rating of “Moderate Buy” and an average target price of $89.92.
Check Out Our Latest Stock Analysis on MetLife
MetLife Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Articles
- Five stocks we like better than MetLife
- What is the Dogs of the Dow Strategy? Overview and Examples
- Tempus AI: A Game-Changer in AI-Powered Healthcare
- Short Selling – The Pros and Cons
- Pelosi Bets Big on AI: This Is What You Need to Know
- How to Calculate Inflation Rate
- Mobileye’s High Short Interest Signals Squeeze Potential
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.